Two Clinical Trials: The Efficacy of Probiotics to Reduce Antenatal GBS

Lisa Hanson, ​PhD, CNM, FACNM, FAAN

Lisa Hanson, ​PhD, CNM, FACNM, FAAN

About Presenter

Dr. Lisa Hanson is Klein Endowed Professor of Women’s Health Research at Marquette University College of Nursing and Associate Director of the Midwifery Program, Milwaukee WI, USA. She practiced as a Certified Nurse-Midwife for 29 years at the Aurora Midwifery and Wellness Center in Milwaukee, WI USA. For over a decade she has worked to develop the science to support the practice of using oral probiotic interventions to reduce antenatal GBS. She currently has two clinical trials in progress that she will discuss.

Disclosures

Corporate sponsored research:
American Lifelines the makers of Florajan3 funded Dr. Lisa Hanson's pilot work 2010-2020. That published pilot study (2014) may be included in the systematic review and meta-analysis. The same company works cooperatively with Dr. Hanson on the NIH Funded/FDA approved study of Florajen3 to reduce GBS colonization. They provide the probiotic and placebo, tested to the FDA required standards, but have no input into study design or conduct.

Other substantive relationships:
Dr. Hanson's research "The efficacy of probiotics to reduce antepartum Group B Streptococcus colonization." is NIH Funded: R21HD095320.
Note: Use of the following drugs or medical devices which may be discussed in this presentation have not been FDA-approved: Florjan3 and Florajen Digestion